Stanford Peng
2020
In 2020, Stanford Peng earned a total compensation of $985.2K as President and Head of Research and Development at Nivalis Therapeutics, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $294,640 |
|---|---|
| Option Awards | $226,605 |
| Salary | $464,000 |
| Total | $985,245 |
Peng received $464K in salary, accounting for 47% of the total pay in 2020.
Peng also received $294.6K in non-equity incentive plan and $226.6K in option awards.
Rankings
In 2020, Stanford Peng's compensation ranked 8,712th out of 13,090 executives tracked by ExecPay. In other words, Peng earned more than 33.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,712 out of 13,090 | 33rd |
Division Manufacturing | 3,710 out of 5,621 | 34th |
Major group Chemicals And Allied Products | 1,497 out of 2,254 | 34th |
Industry group Drugs | 1,304 out of 1,954 | 33rd |
Industry Pharmaceutical Preparations | 963 out of 1,459 | 34th |
Source: SEC filing on April 29, 2022.
Peng's colleagues
We found two more compensation records of executives who worked with Stanford Peng at Nivalis Therapeutics in 2020.